Veteran Nollywood actor, Chidi Mokeme has revealed that he's battling with an incurable disease.
According to him, that was why he took a break from the movie industry and his absence from public events.
Recall that the actor has been trending online since last week, 
following his outstanding performance in the latest Nollywood film on 
Netflix ‘Shanty Town’.
In an interview with Channels Television, Chidi Mokeme revealed 
that he was battling Bell’s Palsy, an ailment he likened to a stroke.
What Is Bell’s Palsy?
Bell’s palsy is a condition that causes sudden weakness in the 
muscles on one side of the face. In most cases, the weakness is 
temporary and significantly improves over weeks.
According to Chidi Mokeme, Bell’s Palsy is an incurable ailment and doctors confirmed there was no treatment for it.
He noted that the ailment affected one side of his face and as an 
actor, he could not make public appearances, hence, decided to take time
 off the movie industry and focus on doing other business.
He said: “Yes, I have been off the scene for a while after we 
did the promotional tour for 76 and we went to the Toronto film 
festival. After that when we were preparing to go to the UK on a trip to
 British International Film Festival. I came down with something called 
Bell’s Palsy.
“It was my first time hearing it and It comes like a stroke and
 affects one side of your face and gives you a droop. And this was 
something the doctor said was incurable. They have no cure because they 
didn’t know what caused it and how to treat it.
“As an actor, if you come out with something that affects your 
face you can imagine and what I was going through at the time. I thought
 it was something I could move around with, I thought I was going to 
come for the biggest premiere of 76 but the attention would be focused 
on me instead of the film. So I decided to take time off and sort out 
that problem that needed my face to be in top shape. So in the main 
time, I just focus on doing my other business.”
 

 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
0 comments:
Post a Comment